6592 POSTER Determination of plasma K-ras mutations in codon 12 in advanced non-small cell lung cancer (NSCLC) patients. Analysis of its prognostic role

2007 ◽  
Vol 5 (4) ◽  
pp. 386
Author(s):  
R. Sirera ◽  
C. Camps ◽  
R. García-Gomez ◽  
N. Viñolas ◽  
A. Artal ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Small Cell Lung ◽  
Prognostic Role ◽  
Ras Mutations ◽  
Nsclc Patients

scholarly journals P2-095: Prognostic value of the determination of K-ras mutations plasma in advanced non-small cell lung cancer (NSCLC) patients

2007 ◽  
Vol 2 (8) ◽  
pp. S528-S529
Author(s):  
Rafael Sirera ◽  
Carlos Camps ◽  
José-Luis González-Larriba ◽  
Juan Lao ◽  
R García-Gómez ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Prognostic Value ◽  
Small Cell ◽  
Small Cell Lung ◽  
Ras Mutations ◽  
Nsclc Patients

Prognostic role of K-Ras mutations in non-small cell lung cancer: Still an issue for open debate

Lung Cancer ◽  
2006 ◽  
Vol 53 (3) ◽  
pp. 393-395 ◽  
Author(s):  
Monica Neri ◽  
Alfredo Cesario ◽  
Pierluigi Granone ◽  
Lorenzo Dominioni ◽  
Riccardo Puntoni ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Small Cell Lung ◽  
Prognostic Role ◽  
Ras Mutations ◽  
Open Debate

scholarly journals Prognostic Role of MicroRNA Let-7 in Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis

2020 ◽  
Author(s):  
Xiaoting Zhang ◽  
Huaning Kang ◽  
Guihong Chen ◽  
Xiaofeng Li
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Meta Analysis ◽  
Small Cell ◽  
Cochrane Library ◽  
Small Cell Lung ◽  
Prognostic Role ◽  
Nsclc Patients

Abstract BackgroundRecent studies have shown that MicroRNAs can be used as potential biomarkers to the prognosis in non-small cell lung cancer (NSCLC). Hence, we conducted this meta-analysis to evaluate the prognostic role of microRNA let-7 in NSCLC patients.MethodsPubMed, Web of Science, Medline and the Cochrane Library were searched for relevant studies. Eligible studies were met specific inclusion and exclusion criteria. Stata 15.1 was used to calculate the pooled parameters.ResultsA total of 11 studies involving 2278 NSCLC patients were included in this meta-analysis. Subgroup analyses established that the heterogeneity was connected with ethnicity and follow-up time. The results suggested that the low expression of microRNA let-7 indicates a poor overall survival rate, with a hazard ratio value of 0.99 (95% CI: 0.64-1.34, P <0.05).ConclusionsLow expression of microRNA let-7 is closely related to the poor prognosis of NSCLC, so microRNA let-7 may become a new biomarker to evaluate the prognosis of NSCLC patients.

Codon 12 K-ras mutations in plasma DNA are not an indicator of disease in non-small-cell lung cancer (NSCLC) patients

2005 ◽  
Vol 23 (16_suppl) ◽  
pp. 7204-7204
Author(s):  
P.-G. Betta ◽  
S. Trombino ◽  
C. Angelini ◽  
M. Neri ◽  
R. Puntoni ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Plasma Dna ◽  
Small Cell Lung ◽  
Ras Mutations ◽  
Nsclc Patients
Sign in / Sign up

Export Citation Format

Share Document